Global CRISPR Market - Dynamics, Trends, Competitor Analysis, and Forecast to 2024

16/mag/2018 14:52:42 PBIGP Contatta l'autore

 

 

Global CRISPR Market: By Product Type (Vector-based Cas, DNA-free Cas), By Application (Functional Genomics, Knockdown/activation, Genome Engineering, Disease models, Other Applications), By Distribution Channel (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others), and Geography - Dynamics, Trends, Competitor Analysis, and Forecast to 2024

 

Market Outline: CRISPR Market

CRISPR is an acronym for Clustered Regularly Interspaced Short Palindromic Repeat. CRISPR is also called as CRISPR/Cas9. The scientific world is attracted by this revolutionary technology. CRISPR technology is a simple yet powerful tool that is used for editing genomes. This technology is used to alter the DNA sequence and modify gene function. Its major application includes correcting genetic defects, treating, and preventing the spread of diseases and is also used improving crops.

 

Market Dynamics: CRISPR Market

The technological advancements are the key factors attributed for the growth of the CRISPR market. Increase in the prevalence of genetic and growing drug discovery activities are expected to boost the market revenue growth. The growing demand for synthetic genes and increase in the R&D expenditure on biotechnology and raising government expenditure on genetic research is enriching the growth of the CRISPR market. However, complications such as gene editing of germ line cells are hindering the growth of the market. Since the changes made in germ line cells are transferred to the next generations. The gene editing of germ line cells also has ethical issues and is illegal in most of the countries such as the UK. Limited awareness is another factor hindering the growth of the CRISPR market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/crispr-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: CRISPR Market

CRISPR market is segmented based on the product type, application, and end user

Based on the product type, the market is segmented into the following:

·         Vector-based Cas

·         DNA-free Cas

Based on the application, the market is segmented into the following:

·         Functional Genomics

·         Knockdown/activation

·         Genome Engineering

·         Disease models

·         Other Applications

Based on the end user, the market is segmented into the following:

·         Biotechnology & Pharmaceutical Companies

·         Academic & Government Research Institutes

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/crispr-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  CRISPR Market

Geographically, global CRISPR market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America CRISPR market expected to be dominant market when compared with that of the other regional markets. The technological advancements, increase in the R&D expenditure, and the increasing government funding expected to create demand for CRISPER. The Asia Pacific is expected to show significant growth over the forecasted period. The growing prevalence of the genetic disorders in the emerging economies such as China and India are expected to boost the market growth of the CRISPR market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/crispr-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: CRISPR Market

Some of the players in the global CRISPR market include:

·         Transposagen Biopharmaceuticals (U.S)

·         Agilent Technologies, Inc. (U.S)

·         Merck KGaA (Germany)

·         Rockland Immunochemicals, Inc. (U.S)

·         Applied StemCell, Inc. (U.S)

·         Cellecta, Inc. (U.S)

·         GeneCopoeia, Inc. (U.S)

·         Horizon Discovery plc (UK)

·         Mirus Bio LLC (U.S)

·         New England Biolabs (U.S)

 

Notable Market Developments: CRISPR Market

Ø  In February 2018, Millipore Sigma has received the Korean Intellectual Property Office and the Israel Patent Office patents for the company's CRISPR technology used in a genomic-integration method for eukaryotic cells

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/crispr-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl